MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients: 5-Year Budget Impact Analysis From the Public Payer Perspective
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.500
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2012
Authors
Publisher
Elsevier BV